does tirzepatide cause gallstones Zepbound Gallbladder Issues? Risks and Symptoms Does GLP-1 Cause Gallbladder Problems?

Date : DMF Number : 39522 Submission : 2024-03-07 Status : Active Type : II NDC Package Code : 84502-113 Start Marketing Date : 2026-05-19 End Marketing Date : 2027-12-31 Dosage Form (Strength) : POWDER (1g/g) Marketing Category : BULK INGREDIENT Registrant Name : Korea Biochem Pharmaceutical Co., Ltd

MNT is the registered trade mark of Healthline Media

It binds to both the GLP-1 receptor and the GIP receptor, which creates a dual mechanism that suppresses appetite , slows gastric emptying, improves insulin sensitivity, and promotes fat metabolism

Expedited reviews (24-72 hours) may be available for urgent clinical situations